APA (7th ed.) Citation

LQ, H., JR, L., JL, G., ML, C., LF, K., BH, H., . . . J, L. (2024). Efficacy of prophylactic antibiotics for the prevention of neutropenic fever in patients with multiple myeloma receiving high-dose cyclophosphamide for stem cell mobilization. Annals of hematology, 103(5), 1601. https://doi.org/10.1007/s00277-023-05537-3

Chicago Style (17th ed.) Citation

LQ, Hou, Liu JR, Gu JL, Chen ML, Kuang LF, Huang BH, Zou WY, and Li J. "Efficacy of Prophylactic Antibiotics for the Prevention of Neutropenic Fever in Patients with Multiple Myeloma Receiving High-dose Cyclophosphamide for Stem Cell Mobilization." Annals of Hematology 103, no. 5 (2024): 1601. https://doi.org/10.1007/s00277-023-05537-3.

MLA (9th ed.) Citation

LQ, Hou, et al. "Efficacy of Prophylactic Antibiotics for the Prevention of Neutropenic Fever in Patients with Multiple Myeloma Receiving High-dose Cyclophosphamide for Stem Cell Mobilization." Annals of Hematology, vol. 103, no. 5, 2024, p. 1601, https://doi.org/10.1007/s00277-023-05537-3.